Sanbox:Kamal: Difference between revisions
Jump to navigation
Jump to search
m (Anmol Pitliya moved page Sanbox: kamal to Sanbox:Kamal without leaving a redirect) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
[[File:Subtrochanteric-neck-of-femur-fracture.jpg|400px|thumb|left|xray showing femur fracture [https://radiopaedia.org/cases/spiral-fracture-of-femur source:Case courtesy of Dr Andrew Dixon, Radiopaedia.org, rID: 25704 ]]] | [[File:Subtrochanteric-neck-of-femur-fracture.jpg|400px|thumb|left|xray showing femur fracture [https://radiopaedia.org/cases/spiral-fracture-of-femur source:Case courtesy of Dr Andrew Dixon, Radiopaedia.org, rID: 25704 ]]] | ||
Line 47: | Line 10: | ||
[[File:Tibial fracture.jpg|400px|thumb|left|X-Ray showing Tibial Fracture [https://radiopaedia.org/cases/proximal-tibia-fracture source:Case courtesy of MD PhD gasssss, Radiopaedia.org, rID: 13768]]] | [[File:Tibial fracture.jpg|400px|thumb|left|X-Ray showing Tibial Fracture [https://radiopaedia.org/cases/proximal-tibia-fracture source:Case courtesy of MD PhD gasssss, Radiopaedia.org, rID: 13768]]] | ||
<br style="clear:left" />==References== | <br style="clear:left" />==References== | ||
==Differentiating NHL== | |||
{| | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | |||
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Etiology | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Constitutional symptoms | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Rash | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Abdominal pain | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Diarrhea | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Mass | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |WBC | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hb | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunochemistry | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Histopathology | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | |||
|- | |||
! rowspan="10" align="center" style="background:#4479BA; color: #FFFFFF;" + |T cell lymphoma | |||
! colspan="2" align="center" style="background:#DCDCDC;" + |Precursor T-cell lymphoblastic leukemia/lymphoma | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Precursor T-cell Lymphomas | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! colspan="2" align="center" style="background:#DCDCDC;" + |Adult T cell leukemia/lymphoma | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! colspan="2" align="center" style="background:#DCDCDC;" + |Anaplastic large cell lymphoma | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Cutaneous T-cell lymphoma | |||
! align="center" style="background:#DCDCDC;" + |[[Mycosis fungoides]] / [[Sézary syndrome]] | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
* The [[tumor]] [[Cell (biology)|cells]] originate from [[memory T cells]] or [[skin]] homing [[CD4+ T cells]] expressing [[cutaneous]] [[lymphocyte]] [[antigen]] (CLA) an<nowiki/>d [[chemokine]] [[receptors]] [[CCR4]]<nowiki/>and CCR7. | |||
* It is understood that cutaneous t cell lymphoma (maycosis fungoides, Sezary sydrome ) is the result of malignant T cell that derived from a mature CD41 CD45RO1 memory T cells. | |||
| align="left" style="background:#F5F5F5;" + | | |||
* [[Epidermis (skin)|Epidermal]] [[atrophy]] or poikiloderma | |||
* Generalized [[itching]]([[pruritus]]) | |||
* [[Pain]] in the affected area of the skin. | |||
* [[Insomnia]] | |||
* Red ([[erythematous]]) patches scattered over the [[skin]] of the [[trunk]] and the [[extremities]] | |||
* [[Weight loss]] | |||
* [[Lymphadenopathy]] | |||
* [[Malaise]] and [[fatigue]] | |||
* [[Anemia]] | |||
* May progress to [[Sezary syndrome]] (Skin involvement plus hematogenous dissemination) | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="left" style="background:#F5F5F5;" + | | |||
* Cutaneous manifestations | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! rowspan="6" align="center" style="background:#DCDCDC;" + |Peripheral T-cell lymphoma | |||
! align="center" style="background:#DCDCDC;" + |Subcutaneous panniculitis-like T-cell lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Hepatosplenic gamma-delta T-cell lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Enteropathy-type intestinal T-cell lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Extranodal T-cell lymphoma, nasal type | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Angioimmunoblastic T-cell lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|- | |||
! align="center" style="background:#DCDCDC;" + |Peripheral T-cell lymphoma, unspecified | |||
| align="center" style="background:#F5F5F5;" + | | |||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | | |||
|} | |||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 20:21, 17 January 2019
==References==
Differentiating NHL
Category | Disease | Etiology | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | Mass | Other | WBC | Hb | Plt | Immunochemistry | Histopathology | Gold standard | Associated findings | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T cell lymphoma | Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||
Adult T cell leukemia/lymphoma |
|
|||||||||||||||
Anaplastic large cell lymphoma |
|
|||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma |
|
||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma |
|
|||||||||||||||
Enteropathy-type intestinal T-cell lymphoma |
|
|||||||||||||||
Extranodal T-cell lymphoma, nasal type |
|
|||||||||||||||
Angioimmunoblastic T-cell lymphoma |
|
|||||||||||||||
Peripheral T-cell lymphoma, unspecified |
|